NDAINJECTIONINJECTABLEPriority Review
Approved
Feb 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
R-GENE 10 (arginine hydrochloride) by Pfizer is clinical pharmacology intravenous infusion of r-gene 10 often induces a pronounced rise in the plasma level of human growth hormone (hgh) in subjects with intact pituitary function. First approved in 1973.
Drug data last refreshed 21h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
R-GENE 10 (arginine hydrochloride) is an intravenous diagnostic agent that stimulates growth hormone (GH) release from the anterior pituitary gland in patients with intact pituitary function. It is used as a provocative test to assess pituitary GH secretory capacity and differentiate normal from pituitary-deficient patients. L-arginine is a natural metabolite with low systemic toxicity.
LOE Approaching
Legacy diagnostic product approaching loss of exclusivity with minimal linked job openings and declining competitive pressure (30/100).
Mechanism of Action
CLINICAL PHARMACOLOGY Intravenous infusion of R-Gene 10 often induces a pronounced rise in the plasma level of human growth hormone (HGH) in subjects with intact pituitary function. This rise is usually diminished or absent in patients with impairment of this function. Expected Plasma Levels of HGH…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
R-GENE 10 presents minimal career growth opportunities given zero linked job openings and LOE approaching status. Roles associated with this legacy diagnostic product would primarily involve revenue maintenance and compliance rather than market expansion or innovation.
Worked on R-GENE 10 at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.